Gill Capital Partners’s Biodesix BDSX Stock Holding History

Gill Capital Partners’s Portfolio BDSX Stock Details BDSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293	Hold	13	–	–	﹤0.01%	665
2026 Q1	$189	Buy	+13	New	+$161	﹤0.01%	661

Other funds holding BDSX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Gill Capital Partners's BDSX Position: Q2 2026 in Review

Gill Capital Partners held its Biodesix (BDSX) position steady in Q2 2026 at 13 shares worth $293. The position accounts for ﹤0.01% of the portfolio, ranked #665.

Gill Capital Partners first reported a position in BDSX in Q1 2026 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

Gill Capital Partners held 13 shares of Biodesix worth $293 as of Q2 2026.
Gill Capital Partners left its Biodesix share count unchanged in Q2 2026.
Biodesix made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #665 holding.
Gill Capital Partners first reported a position in Biodesix in Q1 2026 and has held it in 2 quarters since.
45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.